Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
ECCE MEDICAL from Scherpenheuvel-Zichem, company number BE0767377787, closed financial year 2025 with a result of € 20,881 after tax. For that financial year ECCE MEDICAL recorded a gross margin of € 144,364 and equity of € 106,630. Compared with financial year 2024, the result moved from € 50,849 to € 20,881. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
€ 106,630
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 20,881
▼ 59% vs 2024
Profit after tax over the fiscal year.
€ 301
▼ 69% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 36,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 33,255
▲ 5% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,731
▼ 72% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 292,067
▲ 29% vs 2024
€ 33,035 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 25,831
▼ 55% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 78,942
▲ 49% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 98,270 | € 94,397 | € 184,718 | € 144,364 | ▼ 22% |
| Profit after taxes | € 13,279 | € 7,598 | € 50,849 | € 20,881 | ▼ 59% |
| Equity | € 64,935 | € 71,733 | € 121,750 | € 106,630 | ▼ 12% |
| Total debts | € 345,100 | € 307,240 | € 337,653 | € 397,770 | ▲ 18% |
| Cash | € 29,271 | - | € 974 | € 301 | ▼ 69% |
| Land & buildings | - | - | € 11,121 | € 13,915 | ▲ 25% |
| Retained profit | € 54,935 | € 61,733 | € 111,750 | € 96,630 | ▼ 14% |
| Dividend | € 0 | € 800 | € 833 | € 36,000 | ▲ € 35,167 |
| Bank debt | € 284,710 | € 221,623 | € 226,860 | € 292,067 | ▲ 29% |
| Balance sheet total | € 410,035 | € 378,974 | € 459,403 | € 504,400 | ▲ 10% |
Key figures of ECCE MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ECCE MEDICAL?
What happened at ECCE MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 20,881 (▼ 59% vs 2024). Source: NBB ↗
- New establishment in Scherpenheuvel-Zichem. KBO
- Nico Heylen became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 13,279 profit in 2022 to € 20,881 profit in 2025.
Paid € 53,158 in corporate taxes since 2022.
Best year ever: 2024, with € 50,849 profit.
Paid out € 37,633 in dividends to the owners in total.
A new publication or filing at ECCE MEDICAL? We notify you, reason included.
Follow ECCE MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Nico Heylen
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Langedreef 78
3271 Scherpenheuvel-Zichem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
eccemedical.com
Registered
2001-01-18
Registrar
Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Expires
2027-01-18
Website info
Features
Security
Network
Details
- Company number
- 0767.377.787
- VAT number
- BE 0767.377.787
- Registered office
- Langedreef 78, 3271 Scherpenheuvel-Zichem
- Names & denominations
- ECCE MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 April 2021
- Peppol
- Active · Active since 26 Jul 2024
- Contact
- eccemedical.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en lease van medisch en paramedisch materieel
Groothandel in dranken, algemeen assortiment
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Detailhandel in dranken, algemeen assortiment
Overige zakelijke dienstverlening, neg
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
+2